Journal article
ANNEXATM-R: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, DEMONSTRATING REVERSAL OF RIVAROXABAN-INDUCED ANTICOAGULATION IN OLDER SUBJECTS BY ANDEXANET ALFA (PRT064445), A UNIVERSAL ANTIDOTE FOR FACTOR XA (FXA) INHIBITORS
Authors
Gold AM; Crowther M; Levy G; Lu G; Leeds J; Barron L; Conley P; Castillo J; Curnutte J; Connolly S
Journal
Journal of the American College of Cardiology, Vol. 65, No. 10,
Publisher
Elsevier
Publication Date
March 2015
DOI
10.1016/s0735-1097(15)60023-7
ISSN
0735-1097